Human V5-IRF3-pcDNA3 Citations (10)
Originally described in: High-throughput screening for TLR3-IFN regulatory factor 3 signaling pathway modulators identifies several antipsychotic drugs as TLR inhibitors.Zhu J, Smith K, Hsieh PN, Mburu YK, Chattopadhyay S, Sen GC, Sarkar SN J Immunol. 2010 May 15;184(10):5768-76. Epub 2010 Apr 9. PubMed Journal
Articles Citing Human V5-IRF3-pcDNA3
Articles |
---|
Functional IRF3 deficiency in a patient with herpes simplex encephalitis. Andersen LL, Mork N, Reinert LS, Kofod-Olsen E, Narita R, Jorgensen SE, Skipper KA, Honing K, Gad HH, Ostergaard L, Orntoft TF, Hornung V, Paludan SR, Mikkelsen JG, Fujita T, Christiansen M, Hartmann R, Mogensen TH. J Exp Med. 2015 Aug 24;212(9):1371-9. doi: 10.1084/jem.20142274. Epub 2015 Jul 27. PubMed |
Inhibition of IRF3 expression reduces TGF-beta1-induced proliferation of hepatic stellate cells. Ni MM, Xu T, Wang YR, He YH, Zhou Q, Huang C, Meng XM, Li J. J Physiol Biochem. 2015 Nov 26. PubMed |
Dengue virus subverts host innate immunity by targeting adaptor protein MAVS. He Z, Zhu X, Wen W, Yuan J, Hu Y, Chen J, An S, Dong X, Lin C, Yu J, Wu J, Yang Y, Cai J, Li J, Li M. J Virol. 2016 Jun 1. pii: JVI.00221-16. PubMed |
The IFNL4 Gene Is a Noncanonical Interferon Gene with a Unique but Evolutionarily Conserved Regulation. Zhou H, Mohlenberg M, Terczynska-Dyla E, Winther KG, Hansen NH, Vad-Nielsen J, Laloli L, Dijkman R, Nielsen AL, Gad HH, Hartmann R. J Virol. 2020 Feb 14;94(5). pii: JVI.01535-19. doi: 10.1128/JVI.01535-19. Print 2020 Feb 14. PubMed |
STING and IRF3 in stromal fibroblasts enable sensing of genomic stress in cancer cells to undermine oncolytic viral therapy. Arwert EN, Milford EL, Rullan A, Derzsi S, Hooper S, Kato T, Mansfield D, Melcher A, Harrington KJ, Sahai E. Nat Cell Biol. 2020 Jul;22(7):758-766. doi: 10.1038/s41556-020-0527-7. Epub 2020 Jun 1. PubMed |
A novel mechanism of regulation of the oncogenic transcription factor GLI3 by toll-like receptor signaling. Matissek SJ, Karbalivand M, Han W, Boutilier A, Yzar-Garcia E, Kehoe LL, Gardner DS, Hage A, Fleck K, Jeffers V, Rajsbaum R, Elsawa SF. Oncotarget. 2022 Aug 3;13:944-959. doi: 10.18632/oncotarget.28261. eCollection 2022. PubMed |
The chromatin remodeling protein ATRX positively regulates IRF3-dependent type I interferon production and interferon-induced gene expression. Stilp AC, Scherer M, Konig P, Furstberger A, Kestler HA, Stamminger T. PLoS Pathog. 2022 Aug 8;18(8):e1010748. doi: 10.1371/journal.ppat.1010748. eCollection 2022 Aug. PubMed |
Conserved Functions of Orthohepadnavirus X Proteins to Inhibit Type-I Interferon Signaling. Choonnasard A, Shofa M, Okabayashi T, Saito A. Int J Mol Sci. 2024 Mar 28;25(7):3753. doi: 10.3390/ijms25073753. PubMed |
Multiple inborn errors of type I IFN immunity in a 33-year-old male with a fatal case of COVID-19. Saheb Sharif-Askari N, Hafezi S, Saheb Sharif-Askari F, Ali Hussain Alsayed H, B M Ahmed S, Alsafar HS, Halwani R. Heliyon. 2024 Apr 10;10(8):e29338. doi: 10.1016/j.heliyon.2024.e29338. eCollection 2024 Apr 30. PubMed |
SARS-CoV-2 NSP5 antagonizes MHC II expression by subverting histone deacetylase 2. Taefehshokr N, Lac A, Vrieze AM, Dickson BH, Guo PN, Jung C, Blythe EN, Fink C, Aktar A, Dikeakos JD, Dekaban GA, Heit B. J Cell Sci. 2024 May 15;137(10):jcs262172. doi: 10.1242/jcs.262172. Epub 2024 May 22. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.